Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
A novel CaSR mutation presenting as a severe case of neonatal familial hypocalciuric hypercalcemia.
[familial hypocalciuric hypercalcemia]
Familial
Hypocalciuric
Hypercalcemia
(
FHH
)
is
a
generally
benign
disorder
caused
by
heterozygous
inactivating
mutations
in
the
Calcium
-
Sensing
Receptor
(
CaSR
)
gene
resulting
in
altered
calcium
metabolism
.
We
report
a
case
of
unusually
severe
neonatal
FHH
due
to
a
novel
CaSR
gene
mutation
that
presented
with
perinatal
fractures
and
moderate
hypercalcemia
.
CASE
OVERVIEW
:
A
female
infant
was
admitted
at
2
 
weeks
of
age
for
suspected
non-accidental
trauma
(
NAT
)
.
Laboratory
testing
revealed
hypercalcemia
(
3
.
08
 
mmol
/
L
)
,
elevated
iPTH
(
20
.
4
pmol
/
L
)
and
low
urinary
calcium
clearance
(
0
.
0004
)
.
Radiographs
demonstrated
multiple
healing
metaphyseal
and
rib
fractures
and
bilateral
femoral
bowing
.
The
femoral
deformity
and
stage
of
healing
were
consistent
with
prenatal
injuries
rather
than
non-accidental
trauma
(
NAT
)
.
Treatment
was
initiated
with
cholecalciferol
,
400
 
IU
/
day
,
and
by
6
 
weeks
of
age
,
iPTH
levels
had
decreased
into
the
high
-normal
range
.
Follow
up
radiographs
demonstrated
marked
improvement
of
bone
lesions
by
3
 
months
.
A
CaSR
gene
mutation
study
showed
heterozygosity
for
a
T
>
C
nucleotide
substitution
at
c
.
1664
in
exon
6
,
resulting
in
amino
acid
change
I
555
T
in
the
extracellular
domain
consistent
with
a
missense
mutation
.
Her
mother
does
not
carry
the
mutation
and
the
father
is
unknown
.
At
18
 
months
of
age
,
the
child
continues
to
have
relative
hyperparathyroidism
and
moderate
hypercalcemia
but
is
otherwise
normal
.
This
neonate
with
intrauterine
fractures
and
demineralization
,
moderate
hypercalcemia
and
hyperparathyroidism
was
found
to
have
a
novel
inactivating
missense
mutation
of
the
CaSR
not
detected
in
her
mother
.
Resolution
of
bone
lesions
and
reduction
of
hyperparathyroidism
was
likely
attributable
to
the
natural
evolution
of
the
disorder
in
infancy
as
well
as
the
mitigating
effect
of
cholecalciferol
treatment
.
Diseases
Validation
Diseases presenting
"marked improvement"
symptom
cutaneous mastocytosis
familial hypocalciuric hypercalcemia
familial mediterranean fever
hirschsprung disease
hydrocephalus with stenosis of the aqueduct of sylvius
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom